SFX by Ex Libris Inc.

Title:	IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: Greater mitogenic actions of IGF-I delay differentiation
Source:	Journal of Cellular Physiology [0021-9541] Ewton, Diana yr:1994

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Cell and Developmental Biology Backfiles

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Liu, J P P. "Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)." Cell 75.11 (1993): 59-72.
description	2.	Hollingshead, L A. "IGF-I is required for normal embryonic growth in mice." Genes & development 7.12b: 2609-2617.
description	3.	Florini, Jr. "IGF-I INHIBITS MYOGENESIS UNDER CONDITIONS IN WHICH ITS MITOGENIC ACTIONS CAN OCCUR." Journal of cellular biochemistry (1994): 535-535.
description	4.	Baker, J.. "Role of insulin-like growth factors in embryonic and postnatal growth." Cell 75.1 (1993): 73-82.
description	5.	Holzenberger, -Martin [Author -Reprint-Author] [. "IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice." Nature 421.London (2003): 182-187.
description	6.	DeChiara, T M M. "A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting." Nature 345.6270: 78-80.
description	7.	Ludwig, T. "Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds." Developmental biology 177.2 (1996): 517-535.
description	8.	D'Ercole, A Joseph J. "Mutant mouse models of insulin-like growth factor actions in the central nervous system." Neuropeptides 36.2-3 (2002): 209-20.
description	9.	Rosenthal SM, S M. "Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II." The Journal of clinical investigation 87.4 (1991): 1212-1219.
description	10.	Tee, Andrew R. R. "Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling." Proceedings of the National Academy of Sciences of the United States of America 99.21 (2002): 13571-13576.
description	11.	Hasty, P. "Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene." Nature 364.6437 (1993): 501-6.
description	12.	Norris, M L L. "Role of paternal and maternal genomes in mouse development." Nature 311.5984 (1984): 374-6.
description	13.	Curran, M E E. "The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis." Cell 73.1 (1993): 159-68.
description	14.	DECHIARA, T. "PARENTAL IMPRINTING OF THE MOUSE INSULIN-LIKE GROWTH FACTOR-II GENE." Cell 64.4 (1991): 849-859.
description	15.	Papadakis, M. "Growth hormone replacement in healthy older men improves body composition but not functional ability." Annals of internal medicine 124.8 (1996): 708-16.
description	16.	Dryja, T P. "Molecular etiology of low-penetrance retinoblastoma in two pedigrees." American journal of human genetics 52.6 (1993): 1122-8.
description	17.	Powell-Braxton, L. "Inactivation of the IGF-I gene in mice results in perinatal lethality." Annals of the New York Academy of Sciences 300-301.
description	18.	RUDMAN, D. "EFFECTS OF HUMAN GROWTH-HORMONE IN MEN OVER 60 YEARS OLD." New England Journal of Medicine, The 323.1 (1990): 1-6.
description	19.	Blüher, M. "Extended longevity in mice lacking the insulin receptor in adipose tissue." Science 299.5606 (2002): 572-4.
description	20.	Nicholls, R D D. "Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndrome." Nature 342.6247: 281-285.